Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Frontiers in Cardiovascular Medicine
|
April 3, 2023
Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, et al.
BMJ Open
|
November 14, 2022
Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan
Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, et al.
Frontiers in Cardiovascular Medicine
|
February 10, 2023
The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
July 23, 2003
Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block
Yasuchika Kato, Shin-ichiro Morimoto, Akihisa Uemura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
January 13, 2026
Impact of treatment strategies incorporating sacubitril/valsartan on achievement of guideline-recommended blood pressure targets and representative safety outcomes
Tomohiro Katsuya, Fumiko Nakatsu, Shunsuke Eguchi, et al.
Journal of Arrhythmia
|
August 3, 2017
Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF
Kengo Kusano, Masaharu Akao, Hikari Tsuji, et al.
Journal of Atherosclerosis and Thrombosis
|
September 18, 2025
Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study
Tsutomu Hirano, Yasutaka Takeda, Ichiro Sakuma, et al.
Journal of Cardiology
|
August 15, 2012
Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load
Shinya Hiramitsu, Kenji Miyagishima, Junichi Ishii, et al.
Frontiers in Endocrinology
|
May 16, 2025
Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study
Yasutaka Takeda, Masato Furuhashi, Ichiro Sakuma, et al.
Journal of Cardiology
|
August 19, 2022
Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study
Masaharu Akao, Hikari Tsuji, Kengo Kusano, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Frontiers in Cardiovascular Medicine
|
April 3, 2023
Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, et al.
BMJ Open
|
November 14, 2022
Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan
Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, et al.
Frontiers in Cardiovascular Medicine
|
February 10, 2023
The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
July 23, 2003
Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block
Yasuchika Kato, Shin-ichiro Morimoto, Akihisa Uemura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
January 13, 2026
Impact of treatment strategies incorporating sacubitril/valsartan on achievement of guideline-recommended blood pressure targets and representative safety outcomes
Tomohiro Katsuya, Fumiko Nakatsu, Shunsuke Eguchi, et al.
Journal of Arrhythmia
|
August 3, 2017
Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF
Kengo Kusano, Masaharu Akao, Hikari Tsuji, et al.
Journal of Atherosclerosis and Thrombosis
|
September 18, 2025
Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study
Tsutomu Hirano, Yasutaka Takeda, Ichiro Sakuma, et al.
Journal of Cardiology
|
August 15, 2012
Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load
Shinya Hiramitsu, Kenji Miyagishima, Junichi Ishii, et al.
Frontiers in Endocrinology
|
May 16, 2025
Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study
Yasutaka Takeda, Masato Furuhashi, Ichiro Sakuma, et al.
Journal of Cardiology
|
August 19, 2022
Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study
Masaharu Akao, Hikari Tsuji, Kengo Kusano, et al.
Page
of 6